Biotech penny stocks are some of the most exciting investments. While cheap penny stock picks with small market caps can be aggressive buys, they don’t always have to be “all or nothing” investments.
The bottom line is that stock picks should never by all-out gambles, even when it comes to aggressive penny stock investing strategies. Simply by making sure the company is listed on a major exchange and not traded OTC via pink sheets you can reduce your risk. Also, if you make sure the penny stock in question has decent fundamentals, you can have more faith in your investment.
And when buying pressure and a recent surge in shares is on your side, the potation for a high flying biotech pick is real.
To help you find companies like this, let me offer eight of my favorite biotech penny stocks to buy now:
Lexicon Pharmaceuticals: Since the start of 2011, Lexicon Pharmaceuticals (NASDAQ: LXRX) has watched its stock gain +35%, compared to smaller gains by the broader markets. With a 52-week range of $1.17 to $2.30, LXRX is a biotech penny stock worth looking at.
AVI BioPharma Inc: Biopharmaceutical company AVI BioPharma Inc. (NASDAQ: AVII) has experienced a price increase of +39% in the last 12 months. More recently, the penny stock has gained +12% in the last three months as well. Finally, a quarterly revenue growth of +37%, year-over-year, is another reason this penny stock should be watched.
Dyax Corp: While Dyax Corp’s (NASDAQ: DYAX) stock has not been particularly impressive as of late, the company did report a quarterly revenue growth of +54%, year-over-year, in its last income statement. Also, the company has made progress with its franchise Kalbitor in the last year. Because of its low stock price and various biotherapeutic products, DYAX has the chance to bring large profits to your portfolio.
AEterna Zentaris Inc: In the last 12 months, AEterna Zentaris Inc. (NASDAQ: AEZS) stock has jumped +119% compared to gains of +24% and +18% for the NASDAQ and Dow Jones, respectively. More recently, AEZA has posted a gain of +36% in the last three months, and could strengthen your portfolio.
Vical Inc: After ending 2010 on a low note, Vical Inc. (NASDAQ: VICL) has posted a gain of +5% for 2011. It should also be noted that VICL posted a net revenue growth of +14% in its last income statement as well. Trading just above $2, this penny stock is worth adding your portfolio.
Rexahn Pharmaceuticals: Over the past 90 days, stocks of Rexahn Pharmaceuticals (AMEX: RNN) have gained +50%, compared to smaller gains by the broader markets. More recently, RNN has jumped +9% in the last month as well.
- Related Article: Did a tobacco stock stumble on an Alzheimer’s cure?
Inovio Pharmaceuticals Inc: Biotech company Inovio Pharmaceuticals Inc. (AMEX: INO) has posted a gain of +39% over the past six months. Importantly, INO’s DNA vaccine delivery technology was recently featured in the scientific journal Human Vaccine. If Inovio’s newest technology continues to gain popularity, INO stock may take off.
- Related Article: 6 consumer penny stocks to buy now
CytRx Corp: Finishing off the list is CytRx Corp. (NASDAQ: CYTR), which has posted a gain of +34% in the last six months. With a 52-week range of 62 cents to $1.45, CYTR is an affordable stock that has the potential for big gains.
As of this writing, Louis Navellier did not own a position in any of the stocks named here.
